Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry; Availability

Documents

Comments

Key Dates

Comment Period OpensMar 9, 2026

Comment Period ClosesMay 9, 2026

Type	Title	Posted	Comments	Status
Notice	Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry; Availability FR Doc: 2026-04578	Mar 9, 2026	--

Total Comments

2018-505

CBER

CDER

Responding to FDA Form 483 Observations

at the Conclusion of a Drug CGMP Inspection

Draft Guidance for Industry Availability

OPEN